r/IPO_India

PhonePe processes 47% of India's UPI transactions and earns almost nothing directly from them. That's why the IPO story is much more complicated than it looks.
▲ 18 r/IPO_India+7 crossposts

PhonePe processes 47% of India's UPI transactions and earns almost nothing directly from them. That's why the IPO story is much more complicated than it looks.

TL;DR: PhonePe's core product (UPI) generates almost zero direct revenue - zero MDR is a policy choice, not a temporary inefficiency. The IPO is reportedly largely OFS which means that existing investors are exiting, little to no fresh capital for the company. Valuation already reset from $15B to $9–10.5B as per Reuters. NPCI's 30% market share cap is still live and would force PhonePe to shed a third of its volume if enforced. The monetization story is real but still evolving.

Been digging deep into the PhonePe IPO and I think most discussions are missing the actual core issue.

Everyone focuses on the scale:

  • 700M+ registered users
  • 50M+ registered merchants
  • 47 - 48% UPI market share
  • Walmart backing
  • Potential $9–15B IPO valuation

But the most important fact is this: the core product generates almost no direct revenue.

UPI operates under zero MDR. That's a policy choice, not a temporary market inefficiency.

So every transaction PhonePe processes increases:

  • habit
  • engagement
  • merchant reach
  • infrastructure relevance

…but not necessarily earnings.

The most-used product is also the least monetiszable one.

That's not a bug in the business model. That's the architecture.

The framing most people get wrong

Most fintech IPOs ask: "Can this company grow fast enough?"

PhonePe asks a different question: "Can a company that already became infrastructure convert that position into durable monetization?"

PhonePe has already solved distribution, trust, scale, and frequency.

What it hasn't fully solved yet is monetization at the scale its user base implies.

That's why the valuation debate became much more complicated between late 2025 and early 2026.

The numbers

Metric Detail
FY24 Operating Revenue ₹5,064 Cr
FY25 Operating Revenue ₹7,115 Cr
FY25 Net Loss ₹1,727 Cr
FY25 Adjusted Profit (ex-ESOP) ₹630 Cr
Last Private Valuation $14.5B (Oct 2025)
Jan 2026 IPO Expectation $15B
Reuters reported (Mar 2026) $9–10.5B

Revenue growing 40% YoY. Losses narrowing. ESOP-adjusted, the business turned profitable in FY25 for the first time. Direction is improving. But the path to fully reported profitability is still long.

The IPO twist most retail coverage completely missed

Early reporting assumed PhonePe would raise fresh capital through a standard IPO structure.

That's reportedly not what's happening.

January 2026 reports suggested the IPO may largely be an OFS (Offer For Sale):

  • Walmart reduces stake (~9%)
  • Tiger Global exits fully
  • Microsoft exits fully
  • Little to no fresh capital goes into PhonePe itself

That changes the interpretation significantly.

A fresh issue funds growth. An OFS primarily provides liquidity to existing investors.

So the question is no longer: "Will this IPO help PhonePe expand?"

It becomes: "Is the exit price fair for the business as it exists today?"

That's a very different underwriting conversation.

The Walmart overhang nobody is talking about

Tiger Global and Microsoft reportedly exiting fully actually simplifies things.

Walmart is more complicated.

Even after dilution, Walmart may still retain ~63% ownership post listing.

Public markets won't just price what's being sold now. They'll also price the possibility of future sell downs.

Institutional investors will care a lot about lock-in structure, future secondary sales, and long term ownership intent.

That overhang matters more than most retail discussions acknowledge.

How PhonePe actually plans to make money

Not from UPI directly. UPI is the distribution layer. The monetization thesis sits underneath it.

Insurance
Probably the most mature vertical. Commission income on premium. Natural fit for a high-frequency payments platform.

Lending
Highest-margin business - personal loans, merchant loans, BNPL. Also the most regulated. RBI scrutiny around digital lending has already tightened fintech economics materially.

Wealth and broking
PhonePe is directly competing with Groww, Zerodha, and Upstox through Share.Market, WealthDesk, and OpenQ. Intense competition and relatively thin margins.

Indus Appstore
Long-duration strategic bet. Not meaningful revenue today. But if India's regulatory stance toward app-store concentration tightens further, this becomes a structurally interesting asset over time.

PhonePe-SBI Credit Card
Launched April 2026. Card economics are structurally more monetizable than UPI rails - this matters.

The cross-sell potential is genuinely large.

The problem is conversion visibility.

We still don't have clean data on how effectively PhonePe converts payment users into profitable financial-services customers.

The regulatory risk the market still underestimates

NPCI proposed a 30% cap on UPI market share for any single player.

PhonePe is at 47–48%.

The proposal has been deferred multiple times, most recently to December 2026. It has never been formally withdrawn.

If enforced aggressively, PhonePe may need to shed close to a third of its transaction volume. That directly weakens distribution, engagement, and cross-sell potential - the exact things supporting the financial services monetization thesis.

And this is increasingly becoming competitive, not just regulatory.

April 2026 reports suggested Amazon and Meta were pushing for stronger enforcement around UPI concentration rules - platforms with their own payments ambitions now have direct commercial skin in the game.

The user reach justifying the valuation is inseparable from the dominance a cap would constrain.

The Paytm shadow

Every institutional investor evaluating PhonePe will run some version of the Paytm comparison. Hard to avoid.

Paytm listed at a big premium in November 2021, crashed hard, and the RBI-Paytm Payments Bank crisis in early 2024 fundamentally changed how Indian public markets price fintech scale, regulatory risk, monetization visibility, and profitability timelines.

PhonePe is cleaner strategically, more coherent operationally, and stronger on UPI relevance.

But the market is unlikely to completely remove the fintech regulatory discount. That discount got priced in for a reason.

Where things stand

  • Confidential DRHP filed: September 2025
  • IPO paused: March 2026 (market conditions cited)
  • Revised timeline: not announced

And the valuation conversation already moved materially before a single share traded publicly:

$14.5B private reference → $15B IPO expectation → Reuters reporting $9–10.5B discussions

That's a 40% compression at the starting line.

My take

PhonePe already solved something extremely difficult: distribution at national scale.

700M users. Massive merchant reach. Deep behavioural habit. That's real and not easily replicable.

The unresolved question is whether that distribution converts into durable earnings strong enough to justify a large public market valuation — one that has already reset 40% before listing.

That's what the IPO will ultimately test.

Curious what this sub thinks:

Does PhonePe eventually become a high-margin financial ecosystem built on top of UPI infrastructure?

Or does zero-MDR structurally cap how profitable this model can become?

Not investment advice. Do your own research.

u/ankur_r12 — 2 days ago

81% Revenue CAGR, Low Debt & ₹15 GMP — Vegorama Punjabi Angithi IPO Review: Worth Applying? For discussion only.

Vegorama Punjabi Angithi Limited IPO opened today and the financials look surprisingly strong for an SME issue.

Key Highlights:

IPO Size: ₹38.38 Cr

Price Band: ₹73–₹77

Current GMP: ₹15 (unofficial and unregulated)

P/E Ratio: 11.83x

What stands out:

Revenue jumped from ₹16.91 Cr (FY23) to ₹102.06 Cr (FY25)

PAT grew from ₹0.84 Cr to ₹8.22 Cr

9M FY26 PAT already at ₹9.04 Cr

EBITDA margins improved from 6.88% to 11.81%

Debt-to-equity only 0.15x

For a fast-growing cloud kitchen business, the valuation does not look expensive compared to many recent SME IPOs.

Risks:

  • Highly competitive food delivery space
  • SME liquidity volatility
  • Dependence on delivery platforms

Overall, this looks more like a fundamentally strong growth SME IPO rather than just a listing gains play.

For discussion only.

Disclaimer: The data is taken from website that monitors IPOs and AI is used to refine the presentation.

u/Temporary_Source_558 — 2 days ago

NFP Sampoorna Foods IPO Is Priced At 12.7x P/E — Cheap Growth Story Or Another SME Trap?

A dry fruits company from Delhi just reopened its IPO after withdrawing the issue earlier in January 2026.

Now the interesting part:

• IPO Price Band: ₹52–₹55
• Current GMP: ₹7–₹8 (unofficial and unregulated)
• FY25 EPS: ₹4.31
• P/E: 12.76x
• Revenue already crossed FY25 numbers in just 8 months of FY26
• PAT jumped from ₹1.02 Cr → ₹2.67 Cr → ₹3.49 Cr (8M FY26)
• EBITDA margins reportedly expanding toward ~18%
• IPO Size: ₹24.53 Cr
• NSE SME Listing

But there are a few things investors should probably look at closely:

  1. The IPO Was Earlier Withdrawn The issue was initially withdrawn in January 2026 and is now back for subscription.

Whenever an SME IPO returns to the market, one key question becomes:
What materially changed between the earlier and current filing?

  1. Borrowings Have Increased Sharply Total borrowings reportedly rose to ₹24.94 Cr by November 2025.

That’s a sizeable number relative to the company’s scale, and it also highlights how working-capital intensive this business is.

A portion of IPO proceeds (₹9.5 Cr) will be used for debt repayment.

  1. This Is An Inventory-Driven Business Dry fruit processing is heavily dependent on: • procurement cycles • raw material pricing • imports • inventory management • festive demand

Margins can fluctuate quickly if procurement or demand cycles turn unfavorable.

  1. Growth Momentum Looks Strong This is probably the strongest bullish point.

Revenue generated in just 8 months of FY26 reportedly exceeded the full FY25 revenue figure.

If that growth sustains, the current valuation may look more reasonable.

  1. GMP Is Positive, But Not Extremely High The current GMP is reportedly around ₹7–₹8 against the upper price band of ₹55.

That suggests moderate grey market optimism, not excessive hype. (GMP is unofficial, unregulated, and highly dynamic. It should not be used alone for investment decisions.)

Is this an emerging FMCG-style processing business scaling at the right time…

Or another SME IPO where short-term momentum looks stronger than long-term fundamentals?

For discussion only

Disclaimer: The data is taken from the website monitoring IPOs regularly. AI is used for refinement of the presentation.

u/Temporary_Source_558 — 4 days ago

762x Over Subscription on Goldline Pharmaceutical SME IPO

Goldline Pharma SME IPO closed at 762.37x today. NIIs went absolutely berserk at 1222x, retail at 846x, QIBs at 173x.

As per IPOGuru, Total bids worth around Rs 1,500 crore against a tiny issue size. Allotment's basically a lottery now, especially for retail with 846x oversubscription.

Anyone here applied? Curious what GMP is looking like ahead of listing.

u/SavingsDry3460 — 8 days ago

Goldline Pharma vs RFBL Flexi Pack IPO: Market Sentiment Is Saying Something Interesting

Goldline Pharma vs RFBL Flexi Pack: IPOs Open Today.

PAT: ₹2.83 Cr vs ₹8.33 Cr
Total Income: ₹28.06 Cr vs ₹135.46 Cr
P/E: 10.49x vs 9.74x
Industry: Pharma vs Flexible Packaging
GMP: ₹17 vs ₹0 (unofficial and unregulated)

Despite RFBL being larger in revenue and profit, Goldline currently has stronger grey market sentiment.

Possible reasons:
• Better margin profile
• Asset-light model
• Debt reduction focus

Meanwhile RFBL’s rapid growth also came with higher borrowings and working capital pressure.

For discussion only.

Disclaimer: The data is taken from the website which updates ipo data and ai used to refine the presentation.

u/Temporary_Source_558 — 10 days ago

May 12: Simca closes, Bagmane and Recode list, Goldline and RFBL open

Five IPO actions scheduled for May 12, 2026. Current data from BSE/NSE official streams:

CLOSING (May 12)

  1. Simca Advertising — SME, BSE

- Price Band: ₹174-183

- Lot: 1,200 shares | Min: ₹2,19,600

- Subscription: 4.20x (open until May 12)

- Pre-listing premium: +₹21 (+11.5%)

- Listing: May 15

LISTING (May 12)

  1. Bagmane Prime Office REIT — Mainboard

- Price Band: ₹95-100

- Lot: 150 units | Min: ₹15,000

- Final Subscription: 24.96x

- Pre-listing premium: +₹5 (+5.0%)

- Issue Size: ₹3,405 cr (₹2,390 cr fresh + ₹1,015 cr OFS)

- Listing: BSE + NSE

  1. Recode Studios — SME, BSE

- Price Band: ₹150-158

- Lot: 1,600 shares | Min: ₹2,52,800

- Final Subscription: 217.83x (QIB 137.99x | NII 298.06x | Retail 216.51x)

- Pre-listing premium: +₹42 (+26.6%)

- Issue Size: ₹45 cr (88% fresh issue)

- Listing: BSE SME

OPENING (May 12)

  1. Goldline Pharmaceutical — SME

- Pre-open premium: +₹17 (+39.5%)

- Open: May 12 | Close: May 14 | Listing: May 19

  1. RFBL Flexi Pack — SME

- Pre-open premium: not surfaced

- Open: May 12 | Close: May 14 | Listing: May 19

Source IPO Cracker

https://preview.redd.it/8rkwn9z11j0h1.png?width=1806&format=png&auto=webp&s=e8fe26550eee1a0f15e7920afe3e788b40609648

reddit.com
u/Substantial-Bite-398 — 11 days ago

hello all, I'm completely new to ipo stuff recently started applying I have already applied for " Bagmane Prime Office REIT" hoping I will get allotted who knows if I will not or lol

but recently I have seen this news Zepto ipo so just posting here to see if it will be worth it applying then it come out?

u/my_selfzoro — 14 days ago